Extended survival versus accelerated rejection of nonhuman primate islet allografts: Effect of mesenchymal stem cell source and timing-Reference-Cited by-同舟云学术

Extended survival versus accelerated rejection of nonhuman primate islet allografts: Effect of mesenchymal stem cell source and timing

Published:2021-07-02 Issue:11 Volume:21 Page:3524-3537
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American J Transplantation

Author:

Kenyon Norma S.¹²³⁴^ORCID,Willman Melissa A.¹,Han Dongmei¹,Leeman Rachel S.¹,Rabassa Alex¹,Diaz Waldo L.¹,Geary James C.¹,Poumian‐Ruiz Ena¹,Griswold Anthony J.⁵⁶,Van Booven Derek J.⁵,Thompson Ryan⁷,Ordoukhanian Philip⁷⁸,Head Steven R.⁷⁸,Kenyon Norman M.¹²,McHenry Kenton G.⁹,Salomon Daniel R.⁷,Bartholomew Amelia M.¹⁰,Berman Dora M.¹²^ORCID

Affiliation:

1. Diabetes Research Institute University of Miami Miami Florida USA

2. Department of Surgery University of Miami Miami Florida USA

3. Department of Microbiology and Immunology University of Miami Miami Florida USA

4. Department of Biomedical Engineering University of Miami Miami Florida USA

5. John P. Hussman Institute for Human GenomicsUniversity of Miami Miami Florida USA

6. The Dr. John T. Macdonald Foundation Department of Human Genetics University of Miami Miami Florida USA

7. The Scripps Research Institute La Jolla California USA

8. The Scripps Research Institute Genomics Core Facility La Jolla California USA

9. National Center for Supercomputing Applications University of IllinoisUrbana‐Champaign Chicago Illinois USA

10. Department of Surgery University of Illinois Chicago Illinois USA

Funder

National Institutes of Health

Diabetes Research Institute Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16693

Reference48 articles.

1. Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010

2. Islet Transplantation in Type 1 Diabetes Mellitus Using Cultured Islets and Steroid-Free Immunosuppression: Miami Experience

3. Current Advances and Travails in Islet Transplantation

4. Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

5. Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Status of Allogenic Islet Cell Transplantation;Cells;2023-10-10

2. The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates;Science Translational Medicine;2023-08-30

3. Human umbilical cord mesenchymal stem cell-derived TGFBI attenuates streptozotocin-induced type 1 diabetes mellitus by inhibiting T-cell proliferation;Human Cell;2023-02-25

4. Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats;Nature Communications;2022-12-26

5. Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation;Expert Opinion on Drug Delivery;2022-05-04